Charles Schwab’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-150,241
| Closed | -$8.36M | – | 3206 |
|
|
2017
Q1 | $8.36M | Buy |
150,241
+8,013
| +6% | +$402K | 0.01% | 1432 |
|
|
2016
Q4 | $6.19M | Buy |
142,228
+12,210
| +9% | +$492K | 0.01% | 1597 |
|
|
2016
Q3 | $5.1M | Buy |
130,018
+5,756
| +5% | +$206K | 0.01% | 1641 |
|
|
2016
Q2 | $3.4M | Buy |
124,262
+6,724
| +6% | +$189K | ﹤0.01% | 1797 |
|
|
2016
Q1 | $3.19M | Buy |
117,538
+8,253
| +8% | +$195K | ﹤0.01% | 1790 |
|
|
2015
Q4 | $3.12M | Buy |
109,285
+7,621
| +7% | +$241K | ﹤0.01% | 1824 |
|
|
2015
Q3 | $3.26M | Buy |
101,664
+9,654
| +10% | +$320K | ﹤0.01% | 1760 |
|
|
2015
Q2 | $2.71M | Buy |
92,010
+2,664
| +3% | +$80.4K | ﹤0.01% | 1922 |
|
|
2015
Q1 | $2.75M | Buy |
89,346
+7,888
| +10% | +$252K | ﹤0.01% | 1882 |
|
|
2014
Q4 | $2.27M | Buy |
81,458
+6,117
| +8% | +$159K | ﹤0.01% | 1934 |
|
|
2014
Q3 | $1.71M | Buy |
75,341
+32,741
| +77% | +$648K | ﹤0.01% | 2055 |
|
|
2014
Q2 | $648K | Buy |
42,600
+13,800
| +48% | +$236K | ﹤0.01% | 2524 |
|
|
2014
Q1 | $565K | Buy |
28,800
+5,800
| +25% | +$113K | ﹤0.01% | 2544 |
|
|
2013
Q4 | $435K | Hold |
23,000
| – | – | ﹤0.01% | 2639 |
|
|
2013
Q3 | $208K | Hold |
23,000
| – | – | ﹤0.01% | 2905 |
|
|
2013
Q2 | $146K | Buy |
+23,000
| New | +$109K | ﹤0.01% | 2991 |
|
Other funds holding ZLTQ
Charles Schwab's ZLTQ Position: Q2 2017 in Review
Charles Schwab sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 150,241 shares — an estimated $8.36M sold.
Charles Schwab first reported a position in ZLTQ in Q2 2013 and held it in 16 quarters. The position peaked at $8.36M in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.
- Charles Schwab reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
- Charles Schwab sold 150,241 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $8.36M.
- Charles Schwab first reported a position in ZELTIQ Aesthetics, Inc. in Q2 2013 and held it in 16 quarters.
- Charles Schwab's ZELTIQ Aesthetics, Inc. position peaked at $8.36M in Q1 2017.
- 2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.
Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.